Novavax shares soar 20% premarket after company wins FDA fast-track designation for flu vaccineMarket Watch • 01/15/20
Will Novavax (NVAX) Report Negative Q3 Earnings? What You Should KnowZacks Investment Research • 10/30/19
Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older AdultsGlobeNewsWire • 10/15/19
Novavax to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceGlobeNewsWire • 09/06/19
Novavax, Inc. (NVAX) CEO Stan Erck on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/10/19